OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - RAPTOR PHARMACEUTICAL CORP ownership

Back to all holdings Add to watchlist

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 95 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2016. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2016$403,000,000
+342.9%
75,000
+280.2%
0.01%
+350.0%
Q1 2016$91,000,000–19,726–0.00%–
 Download
Other shareholders

There were no reported owners of RAPTOR PHARMACEUTICAL CORP in Q2 2016.

NameSharesValueWeighting ↓
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders